Reaffirming Commitment to Innovation, Industry Leadership, and Shareholder Value
SOUTH ORANGE, NJ - May 28, 2025 (NEWMEDIAWIRE) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing high-performance filtration solutions to the medical and commercial markets, today announced that they will host an upcoming Analyst and Investor Virtual Event.
Robert Banks, Chief Executive Officer, will deliver an in-depth company presentation to provide a deeper dive into the overall business and its growth drivers at 11am on Monday, June 16th, 2025. A live Q&A session will follow, where investors will have the opportunity to engage directly with company leadership. Chief Financial Officer Judy Krandel will also be available to answer questions.
The Analyst and Investor Virtual Event brings together investors, industry analysts, and business leaders to discuss emerging trends and innovations shaping the water safety landscape.
Event Details:
- Conference: Analyst and Investor Virtual Event
- Date: Monday, June 16, 2025, 11am Eastern Time
- Location: Online
- Presenter: Robert Banks, CEO, Judy Krandel, CFO
For more information and to register, please visit our Registration Page. A replay will be accessible for a limited time following the event.
About Nephros
Nephros is a leading provider of filtration products to the medical, commercial, and industrial markets, offering a wide range of solutions that deliver superior filtration performance. With its advanced hollow-fiber technology and effective commercial filter media, Nephros products help protect against waterborne contaminants, ensuring the highest level of water quality.
For more information about Nephros and its support for water safety, visit nephros.com
Forward-Looking Statements
This release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding Nephros’ expected benefits of the S100 In-Line filter and other statements that are not historical facts, including statements that may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including inflationary factors and general economic conditions, changes in business and competitive conditions, the availability of capital when needed, dependence on third-party manufacturers, distributors and researchers, and regulatory reforms. These and other risks and uncertainties are detailed in Nephros’ reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2024, which it may update in Part II, Item 1A – Risk Factors in its Quarterly Reports on Form 10-Q that it has filed or will file hereafter. Nephros does not undertake any responsibility to update the forward-looking statements in this release.
Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com
Robert Banks, CEO
Nephros, Inc.
(201) 343-5202
robert.banks@nephros.com
Judy Krandel, CFO
Nephros, Inc.
(201) 343-5202
judy.krandel@nephros.com
